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QUESTIONS UNDER STUDY: In the next Swiss National
HIV and Sexually Transmitted Infection (STI) Strategy
2011–2017, STI control will be integrated with HIV pre-
vention. Information is needed which will improve the tar-
geting of professional education. The objective of this
study was to describe the clinical specialities and settings
to which patients with bacterial STI present in Switzerland.
METHODS: We analysed notifications of chlamydia
from 01.08.2008–30.11.2008, and of gonorrhoea and
syphilis from 01.07.2007–30.11.2008. We recorded patient
details, the speciality of the notifying physician and the
setting (primary or secondary care).
RESULTS: We included 2150 notifications of
chlamydia, 1360 of gonorrhoea and 935 of syphilis. In
12.5% of notifications (556/4445) a speciality or setting
could not be assigned. Most chlamydia (1282/2150,
59.6%) and gonorrhoea (902/1360, 66.3%) notifications
were from primary care. Slightly more syphilis
notifications (429/935, 45.9%) were from secondary than
from primary care. General practitioners (GPs) were the
single largest group of specialists notifying gonorrhoea
(609/1360, 44.8%) and syphilis (223/935, 23.9%) and the
second largest speciality notifying chlamydia (446/2150,
20.7%) after gynaecologists in primary care (702/2150,
32.7%). Where male sexual orientation was recorded,
52.5% (180/343) of gonorrhoea cases and 30.3% of
syphilis cases in men who have sex with men (50/165)
were notified by GPs.
CONCLUSIONS: GPs and other specialists in primary
care notify the majority of chlamydia and gonorrhoea and
a substantial percentage of syphilis in Switzerland. These
physicians will be at the forefront of STI management and
secondary prevention to be delivered as part of an
integrated HIV and STI strategy.
Key words: Sexually transmitted infections; disease
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Introduction
Increasing numbers of cases of notifiable bacterial sexually
transmitted infections (STI) in Switzerland have been re-
ported since 1999 [1]. In 2009, provisional reports included
6360 notifications of chlamydia, 964 of gonorrhoea and
863 of syphilis [2]. STI are important infections from a
public health perspective because they are often asympto-
matic but, untreated, can cause severe morbidity includ-
ing ectopic pregnancy, infertility and late complications of
syphilis [3, 4]. STI also facilitate the transmission of HIV
infection [5]. A new strategy for HIV and STI in Switzer-
land (2011 to 2017) is under development; for the first time
STI control will be integrated into HIV prevention [6], as
it is in some other European countries [7]. Information that
helps to target strategies to improve secondary prevention
and clinical care is therefore needed.
There is little direct information about patterns of
health service use by people in Switzerland who have, or
think they might have, an STI [1]. Specialist treatment for
STI is provided by dermatovenereologists but the numbers
of cases diagnosed is a small fraction of all notifications.
Between 1997 and 2003, data from the Swiss Network of
Dermatovenereology Polyclinics showed that diagnoses
from seven centres in major cities in Switzerland
accounted for less than 1% of all notifications of
chlamydia, 12% of gonorrhoea [8], and some 15% of
syphilis before national surveillance was suspended in
1999 [1].






































In Switzerland, laboratories have been required to
report diagnosed cases of chlamydia, gonorrhoea and
syphilis to the Federal Office of Public Health since 1987
[9]. For syphilis, laboratory notification was reintroduced
in 2006 [1]. Since 2006 it has also been obligatory for
physicians to notify cases of gonorrhoea and syphilis [1].
These reports are thought to cover the majority of
diagnosed cases of notifiable STI in Switzerland. The
objectives of this study were to use information about the
source of STI notifications to describe the distributions of
reports of chlamydia, gonorrhoea and syphilis in
Switzerland according to clinical speciality and setting,
and to investigate associations between the clinical setting
and demographic characteristics.
Material and methods
The study period was 01.07.2007 to 30.11.2008 for go-
norrhoea and syphilis, and 01.08.2008 to 30.11.2008 for
chlamydia (earlier records were not retained). We used the
following data sources: for chlamydia, notification forms
of laboratory diagnosed cases (clinical notification is not
required); for gonorrhoea and syphilis, laboratory and
physicians’ notification forms, with physicians’ reports as
the primary source because these were more detailed.
About 40% of syphilis notifications are later confirmed as
cases, compared with >90% of gonorrhoea notifications. In
this paper we use the term cases to mean laboratory con-
firmed cases, and notification to mean a report of a pos-
sible case, with or without subsequent confirmation. All
data were extracted in late 2008 and early 2009 at the Swiss
Federal Office of Public Health. Statistical analyses were
conducted in 2009 and 2010.
For each notification we extracted information on sex
and age and, for syphilis and gonorrhoea, sexual
orientation. Other clinical and behavioural variables were
too incomplete to be usable. We obtained information on
the speciality of the notifying physician and the clinical
setting from the stamp on the report form. For laboratory
reports of chlamydia, we used information on the doctor
or department ordering the test. We matched the name on
the stamp against the online directory of the Swiss
Medical Association (Verbindung der Schweizer
Ärztinnen und Ärzte, FMH (http://www.doctorfmh.ch) to
obtain the clinical speciality, workplace, sex and
graduation year. If a doctor had more than one specialist
title we used the most recent one. Reports from group
practices were assigned a speciality if there was enough
specific information. No individually identifying
information was recorded in datasets, notifications were
not linked to individual physicians, and were identified by
a unique number only.
We grouped clinical specialities, on the basis of a
priori decisions about their likely importance in
diagnosing or managing patients with STI, as follows:
dermatovenereology and infectious diseases (ID, including
tropical medicine); general and internal medicine;
gynaecology; urology; blood donation; and all other
specialities. We then separated these into primary and
secondary care settings. Primary care included single-
handed or group practices, emergency departments,
nursing homes and military clinics. We defined all general
and internal medicine specialists working in single-handed
or group practices as general practitioners (GP).
Secondary care included hospitals, polyclinics, outpatient
departments and health resorts. Screening facilities such as
blood donation centres and laboratories were classified
with secondary care settings. We categorised patient age
as: 0–15; 16–19; 20–24; 25–34; 35–44; 45 years and older.
Sexual orientation for men was categorised as:
heterosexual; homo- or bisexual. Cases amongst women
recorded as having a female sex partner were too few for
analysis.
For each infection we conducted descriptive analyses.
We then used logistic regression models to estimate odds
ratios (OR, with 95% confidence intervals, CI), to
investigate the probability of patients with each infection
being diagnosed in primary care compared with secondary
care settings according to age and sex. We assumed that
for each infection, all observations were independent. We
used Stata version 10 (Stata Corporation, College Station,
Austin, TX) for statistical analysis.
Results
During the study periods there were 2150 notifications of
chlamydia, 1360 of gonorrhoea and 935 of syphilis infec-
tions. In 12.8% of cases (567/4445) overall there was in-
sufficient information to assign a speciality or setting.
Chlamydia cases
Age and sex distribution of laboratory confirmed cases: Of
2150 cases of chlamydia, most were in women (1578/2150,
73.4%) (table 1). Amongst women, the largest numbers
of cases were from 20–24-year-olds (570/1578, 36.1%)
and 25–34-year-olds (513/1578, 32.5%) and in men,
25–34-year-olds (197/539, 36.5%) followed by
35–44-year-olds (133/539, 24.7%).
Clinical setting and specialities: 1838 cases from 24
clinical specialities were notified. For 312 cases the
speciality was unknown and in another 31 cases the
speciality was known but could not be allocated to a
primary or secondary care setting (total missing 16.0%,
343/2150). Overall, 59.6% (1282/2150) of chlamydia
cases were notified from primary care settings and 24.4%
(525/2150) from secondary care (table 1). The single
largest speciality responsible for notifying chlamydia
cases was gynaecology: 51.0%, 1096/2150 of all cases;
54.8%, 702/1282 of primary care cases; and 75.0%, 394/
525 of secondary care cases. GPs notified 34.8% (446/
1282) of cases from primary care settings. Few chlamydia
cases were notified by specialists in dermatovenereology
or ID in primary or secondary care settings (57/2150,
2.7%). The majority of these cases were diagnosed in men
(53/57, 93.0%) and were distributed evenly between
primary and secondary care settings.
Associations with notification from primary care
compared with secondary care: Whilst the number of
notified chlamydia cases in women was higher in primary
than secondary care compared with men, cases in women
were less likely to have been notified from primary than
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from secondary care settings (age-adjusted OR 0.56, 95%
CI 0.44 to 0.71).
Gonorrhoea
Age, sex and sexual orientation of notifications: Of 1360
notifications of gonorrhoea the majority were in men
(1101/1360, 81.0%) (table 2). Amongst men, the largest
numbers of notifications were from 25–34-year-olds (366/
1101, 33.2%) and 35–44-year-olds (331/1101, 30.1%) and
in women, 25–34 year olds (81/241, 33.6%) followed by
20–24 year olds (59/241, 24.5%). Sexual orientation was
reported for 81.0% (892/1101) of male notifications; 38.5%
(343/892) of those with known orientation were men who
have sex with men (MSM).
Clinical setting and specialities: There were 1265
gonorrhoea notifications from 37 settings. For 95
notifications (7.0%) the speciality was unknown and for
an additional one the speciality was known but could not
be allocated to primary or secondary care. Overall, 66.3%
(902/1360) of gonorrhoea notifications were made from
primary care settings and 26.6% (362/1360) from
secondary care (table 2). GPs were the single largest
speciality responsible for gonorrhoea notifications: 44.8%
(609/1360) of all notifications; and 67.5% (609/902) of
those from primary care. Specialists in
dermatovenereology and ID made 12.6% of gonorrhoea
notifications (172/1360) from primary and secondary care
settings combined. GPs accounted for 50.7% (558/1101)
of all notifications in men. Amongst women, 17.4% of
notifications (42/241) were from GPs, compared with
31.1% (75/241) by gynaecologists working in primary
care and 33.6% of gynaecologists (81/241) in secondary
care settings. Men accounted for over 90% of gonorrhoea
notifications from GPs, and from dermatovenereology and
ID physicians and urologists in both primary and
secondary care.
GPs notified approximately half of all gonorrhoea in
both MSM (180/343, 52.5%) and heterosexual men (296/
549, 53.1%) (p = 0.675). Specialists in
dermatovenereology and ID were responsible for 20.7% of
notifications from MSM (71/343) compared with 10.7%
of notifications (59/549) from heterosexual men (p
<0.001).
Associations with notification from primary care
compared with secondary care: Gonorrhoea notifications
in women were less likely to have come from primary
than secondary care settings than in men (age-adjusted OR
0.50, 0.37, 0.66). Notifications in older patients were more
likely to have been made from primary than from
secondary care settings (likelihood ratio test p = 0.050).
Syphilis
Age, sex and sexual orientation of notifications: Of 935 no-
tifications of syphilis 71.1% (665/935) were in men and
27.2% (254/935) in women (table 3). The largest numbers
of male notifications were in 35-44-year-olds (218/665,
32.8%) and men aged 45 years and over (276/665, 41.5%)
and female notifications in 25–34-year-olds (84/254,
33.1%) followed by 35–44 year olds (65/254, 25.6%).
Sexual orientation was reported for only 38.0% of male
syphilis notifications (253/665). Of those with known ori-
entation, 62.5% (165/253) were MSM.
Clinical setting and specialities: 825 notifications
were made from 33 specialities. For 110 notifications the
speciality was unknown and in a further seven the
speciality was known but could not be allocated to a
primary or secondary care setting. Syphilis was as likely
to have been notified from primary care (389/935, 41.6%)
as from secondary care (429/935, 45.9%) settings (table
3). Specialists in dermatovenereology and ID were the
largest group notifying syphilis: 29.0% of all notifications
(271/935); 24.4% from primary care (95/389); 41.0% from
secondary care (176/429). Within primary care, however,
GPs were the largest speciality (223/389, 57.3%). GPs
were responsible for 26.8% of syphilis notifications from
men (178/665), followed by dermatovenereologists and ID
specialists in secondary care (149/665, 22.4%) and other
secondary care specialists (128/665, 19.2%). Similar
numbers of female syphilis notifications were made by
GPs (45/254, 17.7%), secondary care gynaecologists (48/
254, 18.9%) and other secondary care specialists (46/254,
18.1%).










GP 202 (12.8) 232 (43.0) 12 (36.4) 446 (20.7)
Gynaecology 693 (43.9) 6 (1.1) 3 (9.1) 702 (32.7)
Dermatovenereology/ID 2 (0.1) 25 (4.6) 0 (0.0) 27 (1.3)
Urology 5 (0.3) 58 (10.8) 0 (0.0) 63 (2.9)
Other specialities 15 (1.0) 29 (5.4) 0 (0.0) 44 (2.0)
Sub-total 917 (58.1) 350 (64.9) 15 (45.5) 1,282 (59.6)
Secondary care
Gynaecology 389 (24.7) 2 (0.4) 3 (9.1) 394 (18.3)
Dermatovenereology/ID 2 (0.1) 28 (5.2) 0 (0.0) 30 (1.4)
Urology 0 (0.0) 29 (5.4) 1 (3.0) 30 (1.4)
Other specialities 33 (2.1) 31 (5.8) 7 (21.2) 71 (3.3)
Sub-total 424 (26.9) 90 (16.7) 11 (33.3) 525 (24.4)
Missing 237 (15.0) 99 (18.4) 7 (21.2) 343 (16.0)
Total 1,578 (100) 539 (100) 33 (100) 2,150 (100)
GP – general practice (internal medicine and general medicine specialists working in primary care); ID – infectious diseases (including tropical medicine). Column totals
might not add up to exactly 100% due to rounding.
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GPs notified 30.3% of syphilis in MSM (50/165) and
29.5% (26/88) in heterosexual men (p = 0.900). Specialists
in dermatovenereology and ID were responsible for 44.2%
of syphilis notifications in MSM (73/165) and for 36.4%
(32/88) of those in heterosexual men (p = 0.226).
Associations with notification from primary care
compared with secondary care: Women were less likely
than men to have been notified from primary than
secondary care settings (age-adjusted OR 0.67, 95% CI
0.49 to 0.92).
Discussion
This study of notifications of 4445 bacterial STI reported
in 2007 and 2008 has shown that notifications are made by
a wide variety of clinical specialists. The majority of cases
of chlamydia and gonorrhoea, and a substantial percentage
of syphilis cases, were notified from primary care settings.
Within primary care settings, GPs were the speciality most
likely to notify cases of gonorrhoea and syphilis. Gynae-
cologists in primary care were most likely to notify cases
of chlamydia, followed by GPs. Specialists in dermatove-
nereology and ID were responsible for a minority of noti-
fications of all bacterial STI. For all three infections, male
notifications were relatively more likely than female noti-
fications to be made from primary rather than secondary
care settings.
The strengths of this study were that we examined all
notifications of bacterial STI across Switzerland and were
able to assign a clinical setting (primary or secondary) and
a speciality for the majority. These data should therefore
be representative of STI notifications for the whole of
Switzerland. For syphilis, physicians’ notifications include
many subsequently unconfirmed cases, and thus they also
cover settings where patients present with suspected
infections. Limitations of the study design chiefly related
to lack of specificity or missing data. Laboratory
notifications of chlamydia before August 2008 had not
been retained, and hence we examined all records
available during the data entry period. Bias is unlikely
because there was no observed change in reporting
practice over the whole study period, and there were more










GP 42 (17.4) 558 (50.7) 9 (50.0) 609 (44.8)
Gynaecology 75 (31.1) 4 (0.4) 0 (0.0) 79 (5.8)
Dermatovenereology/ID 5 (2.1) 71 (6.4) 1 (5.6) 77 (5.7)
Urology 1 (0.4) 69 (6.3) 0 (0.0) 70 (5.1)
Other specialities 7 (2.9) 60 (5.4) 0 (0.0) 67 (4.9)
Sub-total 130 (53.9) 762 (69.2) 10 (55.6) 902 (66.3)
Secondary care
Gynaecology 81 (33.6) 4 (0.4) 0 (0.0) 85 (6.2)
Dermatovenereology/ID 6 (2.5) 88 (8.0) 1 (5.6) 95 (7.0)
Urology 1 (0.4) 43 (3.9) 1 (5.6) 45 (3.3)
Other specialities 10 (4.1) 123 (11.2) 4 (22.2) 137 (10.1)
Sub-total 98 (40.7) 258 (23.4) 6 (33.4) 362 (26.6)
Missing 13 (5.4) 81 (7.4) 2 (11.1) 96 (7.1)
Total 241 (100) 1,101 (100) 18 (100) 1360 (100)
GP – general practice (internal medicine and general medicine specialists working in primary care); ID – infectious diseases (including tropical medicine). Column totals
might not add up to exactly 100% due to rounding.










GP 45 (17.7) 178 (26.8) 0 (0.0) 223 (23.9)
Gynaecology 32 (12.6) 3 (0.5) 2 (12.5) 37 (4.0)
Dermatovenereology/ID 10 (3.9) 85 (12.8) 0 (0.0) 95 (10.2)
Urology 0 (0.0) 3 (0.5) 0 (0.0) 3 (0.3)
Other specialities 6 (2.4) 25 (3.8) 0 (0.0) 31 (3.3)
Sub-total 93 (36.6) 294 (44.2) 2 (12.5) 389 (41.6)
Secondary care
Gynaecology 48 (18.9) 7 (1.1) 1 (6.3) 56 (6.0)
Dermatovenereology/ID 24 (9.4) 149 (22.4) 3 (18.8) 176 (18.8)
Urology 0 (0.0) 6 (0.9) 0 (0.0) 6 (0.6)
Other specialities 46 (18.1) 128 (19.2) 2 (12.5) 176 (18.8)
Blood donation centres 4 (1.6) 11 (1.7) 0 (0.0) 15 (1.6)
Sub-total 122 (48.0) 301 (45.3) 6 (37.5) 429 (45.9)
Missing 39 (15.4) 70 (10.5) 8 (50.0) 117 (12.5)
Total 254 (27.2) 665 (71.1) 16 (1.7) 935 (100.0)
GP – general practice (internal medicine and general medicine specialists working in primary care); ID – infectious diseases (including tropical medicine). Column totals
might not add up to exactly 100% due to rounding.
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notifications of chlamydia than gonorrhoea or syphilis,
and hence precision was not limited. It is possible that
some notifications were not made by the diagnosing
physician but by a laboratory or another clinical specialist.
We cannot say how many notifications were made by
clinical specialists who did not make the diagnosis, but
only eight notifications in all came from laboratories.
Misclassification in assignment of cases to primary or
secondary care was possible either because of missing
information or because some locations were difficult to
classify. Such misclassification would be non-differential,
biasing associations towards the null. We were unable to
link clinically relevant information to speciality and
setting because of the large amount of missing data. There
are also some limitations in the analysis. We considered all
notifications of each infection as independent
observations. This may not be the case if individuals had
more than one episode diagnosed during the study period.
We believe that this number will be small and will not
have affected the overall results.
As far as we know there are no detailed analyses of the
numbers of cases and distribution of clinical settings in
which bacterial and viral STI in Switzerland are diagnosed
and managed. It was of interest that GPs in Switzerland
accounted for such high proportions of all bacterial STI,
because it is not necessary to have a GP and patients often
have direct access to specialists in primary and secondary
settings. In countries in which GPs are gatekeepers to
secondary care, high proportions of STI diagnoses are
made in primary care. In the Netherlands, for example, it
has been estimated that three quarters of diagnoses of all
STI are made by GPs [10]. A household survey in the
United States, where healthcare is also based on private
insurance, found that 48.6% (95% CI 43.3, 53.9%) of
respondents who reported ever having had an STI had
consulted a private physician or a group practice [11], but
the proportion of these working as GPs was not reported.
The data used in this study reflect clinical practice in
diagnosis and notification and do not necessarily describe
the underlying epidemiology of the infections. For
example, 73.4% of notified chlamydia cases were in
women, whilst 80.2% of gonorrhoea cases were male.
There are no representative population-based surveys of
the prevalence of any STI in Switzerland, but in the US
such studies show similar prevalence rates of gonorrhoea
and chlamydia [12] and, in the UK, similar rates of
chlamydia [13] in women and men. The small proportion
of case notifications of chlamydia from
dermatovenereology of ID clinics (2.7%) is notable, given
that chlamydia is the most common notifiable STI in
Switzerland [2] and the most common cause of male non-
gonococcal urethritis [3]. In the UK, chlamydia accounted
for 30% (113 585/376 508) of all new STI diagnoses in
specialist genitourinary medicine clinics in 2006 [14].
This might reflect ease of access; there are 236 specialist
clinics in the UK [14] compared with seven in
Switzerland. Gynaecologists and GPs notified the majority
of chlamydial infections in Switzerland. Even so, the
diagnosed case rate of chlamydia in Switzerland is
substantially lower than that in countries in northern
Europe that recommend opportunistic testing (data
available from authors, on request). Whilst a degree of
under-reporting is likely, it is thought that the majority of
chlamydia infections in Switzerland remain undiagnosed
[15], contributing to ongoing transmission. The clinical
settings from which STI were notified also reflect clinical
practice, as well as the settings to which patients are most
likely to present. Substantial numbers of syphilis
notifications were made from a wide variety of clinical
specialities in secondary settings; these might have been
identified as positive serological tests for syphilis, which
might have been performed during diagnostic workups for
clinical reasons. Dermatovenereology and ID clinics, the
specialities most associated with syphilis, made the same
number of notifications as from all other hospital settings
combined [4].
The results of this study have implications for clinical
practice, public health and research. Although GPs and
primary care gynaecologists notify about half of all
chlamydia and gonorrhoea cases, the absolute numbers of
cases are small and a single practitioner might deal with
only one or two people with bacterial STI per year. This
study did not provide any information about health-
seeking behaviours or clinical management of common
viral STI such as genital herpes and genital warts. There
are, at present, no clinical guidelines for diagnosis and
management of STI in Switzerland, and they might help to
improve awareness of STI and consistency of clinical
practice. This study suggests that clinical guidelines
should be actively communicated to GPs and specialist
practitioners in primary care settings. Public health policy
in Switzerland will, in future, aim to integrate STI and
HIV prevention [7]. This study provides limited data
supporting the need for a national strategy. In addition,
stronger surveillance systems are needed to monitor trends
in numbers and settings of all STI and HIV diagnoses [7].
Research is also needed to support the implementation and
evaluation of an integrated HIV and STI strategy.
Population-based surveys of the prevalence of both
bacterial and viral STI and surveys of STI in HIV-infected
individuals will help to determine the burden of disease
and the potential for spread, and to evaluate the impact of
new interventions. Additional studies on the health-
seeking behaviour of both men and women with STI-
related problems and physicians’ diagnostic and
management practices will also help to improve the
provision of STI treatment and prevention services. In
summary, GPs and other specialists in primary care
settings notify the majority of chlamydia and gonorrhoea
and a substantial percentage of syphilis cases in
Switzerland. These physicians will be in the forefront of
STI case management and secondary prevention of STI, to
be delivered as part of an integrated HIV and STI strategy.
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